Context: Low-grade inflammation is associated with obesity and the metabolic syndrome
(MetS). Preclinical evidence suggests that resveratrol (RSV) has beneficial metabolic and …

We summarized 16 controlled studies and evaluated the correlation of resveratrol
supplementation with metabolic parameters such as the body weight, waist circumference …

Background There are current trials investigating the effect of resveratrol supplementation
on lipid profiles and liver enzymes among patients with metabolic syndrome (MetS) and …

Background: Obesity and metabolic syndrome are significant global health issues, with
current public health messages predominately focused on altering dietary and physical …

Aim: This study evaluated the effect of resveratrol administration on metabolic syndrome,
insulin sensitivity, and insulin secretion. Methods: A randomized, double-blind, placebo …

Throughout the Western world obesity prevalence is steadily increasing, and associated
metabolic co-morbidities are projected to rise during the years to come. As weight loss and …

Methods: A total of 28 obese men with the MetS were studied during a 35-day stay in the
Rockefeller University Hospital metabolic unit. Subjects were randomized to receive RES 1 …

Background Lipids are ubiquitous metabolites with diverse functions. Excessive lipid
accumulation can trigger lipid redistribution among metabolic organs such as adipose, liver …

Background Effects of resveratrol on metabolic health have been studied in several short-
term human clinical trials, with conflicting results. Next to dose, the duration of the clinical …

Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …